Get startedLog in
    Picture of Percheron Therapeutics logo

    PER — Percheron Therapeutics News Story

    0.000.00%
    au flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapNeutral
    All News

    Brief: Antisense Therapeutics Says Positive Feedback Received On Paediatric Investigation Plan

    Picture of Percheron Therapeutics logoPercheron Therapeutics
    30/09/2021 03:08
    Sept 30 (Reuters) - Antisense Therapeutics Ltd  ANP.AX :
    * GOT A DRAFT OPINION RECOMMENDING AGREEMENT WITH ITS PIP
FOR
DEVELOPMENT OF ATL1102 FOR DUCHENNE MUSCULAR DYSTROPHY

Source ( https://bit.ly/3kRpIHv)
Further company coverage:  ANP.AX 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Percheron Therapeutics

    See all news